ArticleFrontiers in oncology2025

Conversion TORS after neoadjuvant immunotherapy for advanced BOT-SCC: a retrospective study.

Quanquan Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.